Beigene Ltd ADR (NQ: BGNE )
162.54
-0.73
(-0.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Beigene Ltd ADR
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/great-wall-of-china-g88d3f23f5_1280.jpg)
![](https://www.investors.com/wp-content/uploads/2022/03/IT05-Beigene-01-news.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/zai-lab2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/red-blood-cell-gc6575ac93_1920_1.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2104.jpeg)
![](https://cdn.benzinga.com/files/cstone.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20220224006152/en/1199527/5/BGNE_Logo_0821.jpg)
BeiGene Reports Fourth Quarter and Full Year 2021 Financial Results
February 25, 2022
From BeiGene, Ltd.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3601.png)
![](https://mms.businesswire.com/media/20220222005574/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220222005575/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220217005344/en/1363223/5/BGNE_Logo_0821.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From BeiGene, Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20220131005943/en/1344890/4/Dr.-Dugan-HS.jpg)
From BeiGene
Via Business Wire
![](/images/schema-image-default.png)
![](https://mms.businesswire.com/media/20220128005107/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3240.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/wechat-tu_pian__20220124181354.png)
![](https://mms.businesswire.com/media/20220124005223/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-gdd37bc5d2_1920_5.jpg)
![](https://mms.businesswire.com/media/20220120005178/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_401.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3146.png)
![](https://mms.businesswire.com/media/20220106005333/en/1199527/5/BGNE_Logo_0821.jpg)
From BeiGene, Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20220106005053/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image.jpeg)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://investorplace.com/wp-content/uploads/2021/12/bad-etf-sin-stocks.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2930.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.